CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
22,93 USD
+1,28 %+0,29
5. Nov, 02:00:00 Uhr,
Nasdaq
Kommentare 95
Summer.76,
26.07.2021 17:20 Uhr
0
CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients
https://www.globenewswire.com/news-release/2021/07/26/2268442/31386/en/CareDx-Launches-ACROBAT-Study-to-Potentially-Change-Care-Paradigm-for-Stem-Cell-Transplant-Patients.html
ACROBAT is the prospective multi-center study of AlloHeme, to study the potential of relapse surveillance for stem cell transplant patients
...
Summer.76,
08.06.2021 16:49 Uhr
0
CareDx To Acquire Transplant Hero Medication Management Application
https://www.globenewswire.com/news-release/2021/06/08/2243452/31386/en/CareDx-To-Acquire-Transplant-Hero-Medication-Management-Application.html
Acquisition adds to growing digital portfolio for patients and transplant centers
Summer.76,
07.06.2021 22:13 Uhr
0
CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance
https://www.globenewswire.com/news-release/2021/06/07/2242580/31386/en/CareDx-Presents-Landmark-KOAR-1000-Data-Demonstrating-Higher-1-Year-Graft-Survival-and-Reduction-in-Biopsies-through-ARTS-Surveillance.html
KOAR is the largest prospective validation study on AlloSure surveillance with over 1,500 patients enrolled
Summer.76,
04.06.2021 18:42 Uhr
0
CareDx Advances Artificial Intelligence in Transplantation
Partnership with OrganX to develop decision support systems
https://www.globenewswire.com/news-release/2021/06/03/2241712/31386/en/CareDx-Advances-Artificial-Intelligence-in-Transplantation.html
CareDx Presents Groundbreaking AlloSure® Data at the 2021 American Transplant Congress
https://markets.businessinsider.com/news/stocks/caredx-presents-groundbreaking-allosure-data-at-the-2021-american-transplant-congress-1030494698
Summer.76,
01.06.2021 17:10 Uhr
0
CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, Prospective Study of LiverCare
https://www.globenewswire.com/news-release/2021/06/01/2239480/0/en/CareDx-Starts-Enrollment-in-MAPLE-a-Multi-modal-Multi-center-Prospective-Study-of-LiverCare.html
Study to demonstrate utility of LiverCare post-transplant surveillance for liver transplant recipients
Summer.76,
29.05.2021 7:52 Uhr
0
CareDx Announces Strategic Minority Investment in Miromatrix
https://www.globenewswire.com/news-release/2021/05/28/2238527/0/en/CareDx-Announces-Strategic-Minority-Investment-in-Miromatrix.html
Participation in Series C and Research Partnership to Advance Development of Bioengineered Transplantable Organs
Summer.76,
05.05.2021 22:33 Uhr
0
https://www.globenewswire.com/news-release/2021/05/05/2223806/0/en/CareDx-Reports-First-Quarter-2021-Results.html
Summer.76,
22.04.2021 18:18 Uhr
0
CareDx Announces Palmetto MolDx Finalized Local Coverage Determination 'Molecular Testing For Solid Organ Allograft Rejection'
https://pub.webull.com/us/news-html/a66afe0fa5cb42f8a1c81b0cb9086b6d.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en
Summer.76,
22.04.2021 18:17 Uhr
0
CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients
https://www.biospace.com/article/releases/caredx-to-debut-multicenter-data-on-allosure-lung-an-analytically-and-clinically-validated-biomarker-of-graft-injury-for-lung-transplant-patients/
Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual Meeting
...today announced that experts will be presenting 22 clinical abstract presentations at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, to be held between April 24-28, 2021. ...
M
Mswift,
08.04.2021 14:24 Uhr
0
https://www.globenewswire.com/news-release/2021/04/08/2206544/31386/en/CareDx-Announces-New-HLA-Typing-Service-Offering-for-Research-Purposes.html
Summer.76,
17.03.2021 14:26 Uhr
0
CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular
https://www.globenewswire.com/news-release/2021/03/17/2194384/0/en/CareDx-Strengthens-Bioinformatics-Capabilities-with-Acquisition-of-BFS-Molecular.html
Summer.76,
25.02.2021 15:41 Uhr
0
https://pub.webull.com/us/news-html/64049e90a6b142acb612869f513c193f.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en
Raymond James analyst Andrew Cooper maintains CareDx (NASDAQ:CDNA) with a Strong Buy and lowers the price target from $101 to $98.
Summer.76,
25.02.2021 15:40 Uhr
0
CareDx Expands into the Pre-Transplant Kidney Space through TX Connect
https://www.globenewswire.com/news-release/2021/02/25/2182278/0/en/CareDx-Expands-into-the-Pre-Transplant-Kidney-Space-through-TX-Connect.html
TX Connect adds 19,000 patient referrals for kidney transplant and continues CareDx’s focus on the patient journey
...
Summer.76,
24.02.2021 22:22 Uhr
0
CareDx Reports Fourth Quarter and Full Year 2020 Results
https://finance.yahoo.com/news/caredx-reports-fourth-quarter-full-210100080.html
Recent Highlights:
• Achieved total revenue of $58.6 million for the three months ended December 31, 2020, increasing 64% over prior year fourth quarter
• Delivered record full year revenue of $192.2 million, an increase of 51% compared with full year 2019 revenue
• Provided over 25,000 patient results in the fourth quarter and approximately 79,000 patient results in 2020
• Generated GAAP net loss of $3.5 million, non-GAAP net income of $4.3 million, and positive adjusted EBITDA of $4.9 million in the fourth quarter
• As of December 31, 2020, over 55 U.S.-based transplant centers have adopted an AlloSure Kidney testing protocol
• Received Medicare reimbursement pricing for AlloSure Heart
....
Summer.76,
11.02.2021 5:04 Uhr
0
BRIEF-Ark Investment Management Llc Reports A Passive Stake Of 10.54% In CareDx Inc As Of Jan. 31, 2021
https://pub.webull.com/us/news-html/12ba70cf914647c5afe835a27cedb190.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en
Caredx jumps 10% after Cathie Wood’s ARK takes 10.5% stake
https://seekingalpha.com/news/3660957-caredx-stock-rises-10-on-ownership-disclosure
• ARK Investment Management discloses 5.19M share ownership in CareDX (NASDAQ:CDNA), representing 10.54%.
• The shares contain voting power.
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Trading- und Aktien-Chat | ||
2 | Nio für normale Kommunikation | +0,98 % | |
3 | Phunware Hauptdiskussion | +2,52 % | |
4 | für alle, die es ehrlich meinen beim Traden. | ||
5 | Aktien und Saunaclub alla Luci | ||
6 | BP Hauptdiskussion | +1,64 % | |
7 | SIXT AG Hauptdiskussion | -1,64 % | |
8 | Aktuelles zu Almonty Industries | +2,26 % | |
9 | Palantir | -1,19 % | |
10 | Renk Group | -1,81 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | Nio für normale Kommunikation | +0,98 % | |
2 | Phunware Hauptdiskussion | +2,52 % | |
3 | BP Hauptdiskussion | +1,64 % | |
4 | Aktuelles zu Almonty Industries | +2,26 % | |
5 | Palantir | -1,19 % | |
6 | SIXT AG Hauptdiskussion | -1,64 % | |
7 | NVIDIA Hauptdiskussion | +0,48 % | |
8 | LUFTHANSA Hauptdiskussion | -1,16 % | |
9 | XIAOMI CORP. CL.B Hauptdiskussion | -0,86 % | |
10 | YNVISIBLE INTERACTIVE Hauptdiskussion | +5,77 % | Alle Diskussionen |